JPRN-UMIN000009517已完成未知
Clonal deletion of T lymphocytes against host organ by early post-transplant cyclophosphamide: clinical study of GVHD prophylaxis in HLA-haploidentical bone marrow transplantation - HLA-haploidentical BMT using post-transplant CY
Osaka medical center and research institute for maternal and child health0 个研究点目标入组 15 人开始时间: 2012年12月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Having a severe complication (NCI-CTCAE ver3.0 Grade II or more). 2. Having an uncontrolled infection. 3. Physician's decision.
研究者
相似试验
尚未招募
不适用
Induction of neo*antigen specific cytotoxic T cells by autologous tumor lysate-loaded specialized cross*presenting dendritic cells in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy, the NEODOC studyhigh grade serous ovarian cancer10038594ovarian cancerepithelial ovarian cancerNL-OMON54480Radboud Universitair Medisch Centrum10
尚未招募
不适用
Detection of unshared-HLA restricted T lymphocytes in HLA mismatched hematopoietic stem cell transplantatioPatients with hematologic disorder who undergoing HLA mismatched hematopoietic stem cell transplantationJPRN-UMIN000044095Hyogo College of Medicine30
进行中（未招募）
不适用
Administration of leukemia-reactive donor T cells after allogeneic stem cell transplantation or donor lymphocyte infusion to patients with persistent or relapsed mature B cell neoplasm with blood and/or bone marrow involvementpersistent or relapsed mature B cell neoplasm with blood and/or bone marrow involvementEUCTR2012-003691-40-NLeiden University Medical Center
已完成
2 期
Administration of leukemia-reactive donor T cells after allogeneic stem cell transplantation or donor lymphocyte infusion to patients with persistent or relapsed mature B cell neoplasm with blood and/or bone marrow involvementleukemialymfomen10024324lymphomaNL-OMON37016eids Universitair Medisch Centrum4
招募中
不适用
Investigation of drug specific cytotoxic T cell in severe cutaneous adverse drug reactioJPRN-UMIN000009708Yokohama City University Graduate School of Medicine10